1H21 revenue increased 6.8% y-o-y to US$210.5m; EBITDA increased 3.6% y-o-y to US$26.5m. The higher revenue in 1H21 was mainly due to a recovery in sales in 2Q21 as Delfi was impacted by the severe lockdowns in 2Q20. While sales in 1Q21 was close to pre-COVID levels (c.6% below), sales in 2Q21 was c.19% below […]

Read more of this post